HLB Life Science Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 123.15 million compared to KRW 122.15 million a year ago. Net income was KRW 13,659.26 million compared to net loss of KRW 10,367.5 million a year ago.

Basic earnings per share from continuing operations was KRW 142 compared to basic loss per share from continuing operations of KRW 103.6419 a year ago. Diluted earnings per share from continuing operations was KRW 142 compared to diluted loss per share from continuing operations of KRW 103.6419 a year ago. Basic earnings per share was KRW 142 compared to basic loss per share of KRW 109 a year ago.